[Skip to Content]
[Skip to Content Landing]
Views 272
Citations 0
Comment & Response
July 18, 2017

Screening Pelvic Examinations—Reply

Author Affiliations
  • 1Washington Health Research Institute, Kaiser Permanente, Seattle
  • 2University of California, San Francisco
  • 3University of Iowa, Iowa City
JAMA. 2017;318(3):300-301. doi:10.1001/jama.2017.7837

In Reply The USPSTF acknowledges the concerns expressed by Dr Qaseem and colleagues regarding our recent recommendation statement on screening for gynecologic conditions with pelvic examination. The USPSTF has a long history of informing primary care clinicians when it believes that the certainty of the evidence is too low to make a recommendation, as was determined in this case. The USPSTF’s assessment of the evidence on the pelvic screening examination resulted in an I statement, which reflects insufficient evidence to recommend for or against providing a specific preventive service. Recognizing that the I statement can lead to some uncertainty regarding clinical decision making, the USPSTF provides guidance to clinicians in the recommendation statement on how to interpret and use the I statement and, in addition, identifies key research gaps that must be addressed for an I statement to become an A, B, C, or D grade recommendation.

First Page Preview View Large
First page PDF preview
First page PDF preview